Company patents
Sight Sciences, Inc.
Sight Sciences, Inc. demonstrates a strong focus on medical devices, with Implants & Prosthetics accounting for 89.1% of its portfolio, experiencing a significant surge in 2024 (+250.0% YoY) before a decline in 2025 and so far in 2026. While maintaining a notable presence in Pharmaceutical Preparations (26.1% of portfolio), the company appears to be shifting away from Drug Delivery Devices and Therapeutic Activity (Pharma), both showing substantial declines in patenting activity in 2025 and so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
46 US filings (since 2023) · 6 categories · 5 themes
Integrated systems and specialized instruments for performing delicate surgical procedures on the eye, often involving the delivery, manipulation, or monitoring of ophthalmic implants.
Implantable devices designed to manage or redirect bodily fluids, including stents for ducts, and systems for draining or accumulating fluids within internal cavities.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Implantable devices that deliver electrical, optical, or other forms of energy to stimulate tissues or nerves, or sense physiological parameters for therapeutic purposes.
Patents
Showing 1-10 of 76